No insider purchase over the last 90 days. The latest, by Nelson Todd Robert, was filed 14 Nov 2022.
This page follows insider dealings at Telesis Bio Inc. as filed with SEC (Form 4). Telesis Bio Inc. has had no insider filing for more than a year; the last one goes back to 26 July 2024.
Our records for Telesis Bio Inc. go back to 2021, with 3 purchases and 3 sales on the open market in total.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 47 declarations
Telesis Bio Inc. is a biotechnology company focused on developing solutions for DNA synthesis. It is listed on the XNAS market.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2023 | 27.5 m USD | -47.7 m USD | -1.64 USD | 10-K |
| Dec 2022 | 27.4 m USD | -48.5 m USD | -1.65 USD | 10-K |
| Dec 2021 | 11.0 m USD | -39.0 m USD | -2.14 USD | 10-K |
| Dec 2020 | 6.6 m USD | -18.0 m USD | -3.60 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.